Study shows MS treatments delay progression of the disease

January 17, 2019

An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important.

The Royal Melbourne Hospital and University of Melbourne-led study is the first to provide evidence that the currently available therapies can delay progression of disability in multiple sclerosis. The international study used data from 1555 patients, from 68 neurological clinics across 21 countries. It showed that early treatment – particularly within five years of onset – delayed the secondary progressive stage of MS, which is characterized by an ongoing increase of disability.